1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014

Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014" provides data on the Iron Deficiency Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Iron Deficiency Anemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Iron Deficiency Anemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Iron Deficiency Anemia Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Iron Deficiency Anemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Iron Deficiency Anemia 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Iron Deficiency Anemia Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Iron Deficiency Anemia 34
Dec 08, 2014: American Regent Announces Clinical Data Presentations at ASH 2014 34
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Galenica Ltd. 36
Clinical Trial Overview of Galenica Ltd. 36
Daiichi Sankyo Company, Limited 38
Clinical Trial Overview of Daiichi Sankyo Company, Limited 38
Pharmacosmos A/S 40
Clinical Trial Overview of Pharmacosmos A/S 40
AMAG Pharmaceuticals, Inc. 41
Clinical Trial Overview of AMAG Pharmaceuticals, Inc. 41
Rockwell Medical, Inc. 42
Clinical Trial Overview of Rockwell Medical, Inc. 42
Shield Therapeutics 43
Clinical Trial Overview of Shield Therapeutics 43
Actavis plc 44
Clinical Trial Overview of Actavis plc 44
Laboratoires Pierre Fabre SA 45
Clinical Trial Overview of Laboratoires Pierre Fabre SA 45
Keryx Biopharmaceuticals, Inc. 46
Clinical Trial Overview of Keryx Biopharmaceuticals, Inc. 46
Clinical Trial Overview of Top Institutes / Government 47
Swiss Federal Institute of Technology 47
Clinical Trial Overview of Swiss Federal Institute of Technology 47
Eunice Kennedy Shriver National Institute of Child Health and Human Development 48
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 48
University of Zurich 49
Clinical Trial Overview of University of Zurich 49
Soroka University Medical Center 50
Clinical Trial Overview of Soroka University Medical Center 50
Wageningen University 51
Clinical Trial Overview of Wageningen University 51
Stanford University 52
Clinical Trial Overview of Stanford University 52
University of Oxford 53
Clinical Trial Overview of University of Oxford 53
The Hospital for Sick Children 54
Clinical Trial Overview of The Hospital for Sick Children 54
Imperial College London 55
Clinical Trial Overview of Imperial College London 55
HaEmek Medical Center 56
Clinical Trial Overview of HaEmek Medical Center 56
Five Key Clinical Profiles 57
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 105

List of Tables
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Iron Deficiency Anemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Iron Deficiency Anemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Iron Deficiency Anemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Iron Deficiency Anemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Iron Deficiency Anemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2014* 15
Iron Deficiency Anemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Iron Deficiency Anemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2014* 18
Iron Deficiency Anemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Iron Deficiency Anemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Iron Deficiency Anemia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Iron Deficiency Anemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Iron Deficiency Anemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Iron Deficiency Anemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Galenica Ltd., 2014* 36
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 38
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacosmos A/S, 2014* 40
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AMAG Pharmaceuticals, Inc., 2014* 41
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rockwell Medical, Inc., 2014* 42
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shield Therapeutics, 2014* 43
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 44
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2014* 45
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Keryx Biopharmaceuticals, Inc., 2014* 46
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Federal Institute of Technology, 2014* 47
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 48
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014* 49
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Soroka University Medical Center, 2014* 50
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Wageningen University, 2014* 51
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 52
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 53
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014* 54
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 55
Iron Deficiency Anemia Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014* 56

List of Figures
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Iron Deficiency Anemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Iron Deficiency Anemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Iron Deficiency Anemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Iron Deficiency Anemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Iron Deficiency Anemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2014* 15
Iron Deficiency Anemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Iron Deficiency Anemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Iron Deficiency Anemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2014* 18
Iron Deficiency Anemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Iron Deficiency Anemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Iron Deficiency Anemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Iron Deficiency Anemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Iron Deficiency Anemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Sepsis Diagnostics Market by Technology, Product, Method, Usability, Pathogen - Global Forecast to 2021

Sepsis Diagnostics Market by Technology, Product, Method, Usability, Pathogen - Global Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The sepsis diagnostics market is expected to reach USD 564.1 million by 2021, at a CAGR of 8.8% from 2016 to 2021. The sepsis diagnostics market is primarily driven by the rising prevalence of sepsis in ...

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy

  • $ 4995
  • Industry report
  • November 2016
  • by GBI Research

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy Summary Hemophilia ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.